Submit your next manuscript to Cancer Informatics and take full advantage of:
Convenient three-step online manuscript submission system
High quality peer review service & average 3 weeks to editorial decision
Accessible journal staff & frequent manuscript status updates
No color charges and no limits on number of figures or movies
Inclusion in Pubmed, CAS and Scopus
Compliance with major open access mandates
Research which is freely available for redistribution
We live in a time when it is widely recognized that scientific collaborations across traditional disciplines can yield exponential gains through synergy. Cancer research is currently benefiting from advances in many fields, including biology (genomics and proteomics), physical chemistry (mass spectrometry and radio imaging), computer science and biostatistics (machine learning, artificial intelligence), and many others. Medical informatics is a field nearly as wide that includes patient information systems and related critical components of information management in the information age.
Cancer Informatics is accepting manuscripts now. Submit your manuscript here.
Dr J. T. Efird
Editor in Chief
Compared with other journals we considered for publishing, Cancer Informatics provided extremely rapid but quality turnaround from draft submission to a flawlessly typeset final publication. Moreover, sharing the article is now as easy as sharing a link with no subscriptions required, and additional code and data files are equally accessible, supporting reproducible research. Because it has published many of our references we feel confident that our target readership must follow the journal. This is further ...
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.See Our Results
Copyright © 2013 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)